| 英文别名 |
A-PENTASACCHARIDE;Blood group A antigen pentaose type 1 - 5 mg;Blood group A pentasaccharide;2)]-O-b-D-galactopyranosyl-(1®A-PENTA;A-PENTA A-PENTASACCHARIDE Α-D-GALNAC-(1-3)-[Α-L-FUC-(1-2)]-Β-D-GAL-(1-4)-[Α-L-FUC-(1-3)]-D-GLC ALPHA-D-GALNAC-(1->3)-[ALPHA-L-FUC-(1->2)]-BETA-D-GAL-(1->4)-[ALPHA-L-FUC-(;D-Glucose,O-2-(acetylamino)-2-deoxy-a-D-galactopyranosyl-(1®blood group A antigen pentaose type 1;D-Glucose,o-2-(acetylamino)-2-Deoxy-a-d-galactopyranosyl-(1(R)3)-O-[6-deoxy-a-L-galactopyranosyl-(1(R)2)]-O-b-D-galactopyranosyl-(1(R)4)-O-[6-deoxy-a-L-galactopyranosyl-(1(R)3)]-;N-[(2R,3R,4R,5R,6R)-2-[(2S,3R,4S,5S,6R)-3-[(2S,3S,4R,5S,6S)-6-ethyl-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(2R,3R,4R,5R)-4-[(2S,3S,4R,5S,6S)-6-ethyl-3,4,5-trihydroxyoxan-2-yl]oxy-5,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide;50624-46-9;GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Gal;N-[2-[3-(6-ethyl-3,4,5-trihydroxyoxan-2-yl)oxy-2-[4-(6-ethyl-3,4,5-trihydroxyoxan-2-yl)oxy-5,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide |